Neuralstem (NASDAQ:CUR) and Seagen (NASDAQ:SGEN) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.
Profitability
This table compares Neuralstem and Seagen's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Neuralstem | -39,417.64% | -170.51% | -110.16% |
Seagen | 25.34% | 20.46% | 16.67% |
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Neuralstem and Seagen, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Neuralstem | 0 | 0 | 0 | 0 | N/A |
Seagen | 1 | 5 | 11 | 1 | 2.67 |
Seagen has a consensus price target of $188.4615, indicating a potential upside of 23.54%. Given Seagen's higher probable upside, analysts plainly believe Seagen is more favorable than Neuralstem.
Insider and Institutional Ownership
38.3% of Neuralstem shares are owned by institutional investors. Comparatively, 87.2% of Seagen shares are owned by institutional investors. 5.4% of Neuralstem shares are owned by insiders. Comparatively, 31.1% of Seagen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Valuation & Earnings
This table compares Neuralstem and Seagen's top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Neuralstem | $260,000.00 | 11.71 | $-4,930,000.00 | N/A | N/A |
Seagen | $916.71 million | 30.15 | $-158,650,000.00 | ($1.33) | -114.70 |
Neuralstem has higher earnings, but lower revenue than Seagen.
Risk and Volatility
Neuralstem has a beta of 1.81, indicating that its share price is 81% more volatile than the S&P 500. Comparatively, Seagen has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500.
Summary
Seagen beats Neuralstem on 10 of the 12 factors compared between the two stocks.